drugset / Trial / NCT00464763

A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery

NCT00464763 ↗

Phase 3 Withdrawn Pfizer
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to evaluate the efficacy and safety of dexmedetomidine in the prevention of postoperative delirium in subjects undergoing heart valve surgery with or without coronary artery bypass surgery (CABG) using cardiopulmonary bypass (CPB).

Timeline

Start
2007-04
Primary completion
—
Completion
2007-09

Outcome

Outcome not reported

Stopped: “The incidence of post-operative delirium observed from interim blinded data in DEX-06-09 was significantly lower than the current literature in this population.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — Intravenous

Indications